"Because I've avoided the mirror for so long, now I'm trying to stare more into it, stare more deeply and see that reflection and let it catch up to my brain."
() received FDA approval in 2005, becoming the first GLP-1 receptor agonist for Type 2 diabetes
14,15 Screening for eating disorders should also be completed before prescribing GLP1 RAs, with referral of patients to a specialist as appropriate
Novo Nordisk last month filed a petition to add semaglutide, the key ingredient in Ozempic and Wegovy, to an FDA list of drugs deemed too difficult to compound safely
The Bottom Line on CJC-1295 / Ipamorelin CJC 1295/Ipamorelin may offer an effective peptide combination for health optimization in some individuals
Friday's FDA approval of Zepbound for treating moderate to severe sleep apnea came after the SURMOUNT-OSA phase 3 clinical trials -- two randomized, double-blind, placebo-controlled studies of 469 adults without type 2 diabetes